ERT moves into trial management software with eClinical Insights acquisition

By Zachary Brennan

- Last updated on GMT

ERT moves into trial management software with acquisition

Related tags Ert Clinical trial

Patient safety and efficacy endpoint data collector ERT has acquired eClinical Insights (eCI), a provider of cloud-based clinical trials management software, for an undisclosed sum.  

ERT and eClinical Insights share a common vision of changing the paradigm of clinical research technology​,” states Jim Corrigan, President and CEO of ERT. “For over 40 years, ERT's combined platforms have been used by global pharmaceutical companies to improve clinical trial study design, data analysis and trial execution. We are excited to extend our proven eClinical offering through the introduction of eCI’s innovative cloud based software platform, which enables our customers to integrate data from multiple systems, get full visibility across the key aspects of their trials, and benefit from real-time decision making​.”

ERT and eCI say their shared goal is to empower clinical trial sponsors and CROs with real-time insight into performance, risk, and outcomes trending, enabling them to achieve their goals of decreasing clinical trial costs while increasing trial quality.

The acquisition further strengthens ERT’s position in clinical research by offering a software solution that simplifies data collection, analytics, visibility and exchange in a complex global environment.

Scott Dixon, VP of marketing and strategy at ERT, told that there will not be any layoffs associated with the acquisition. "It’s going to help us grow further and it will offer us some scalability​," he said.

On average, clinical trial sponsors utilize between 5-7 systems for data collection from disparate vendors. ERT and eClinical Insights are looking to cut that number by extending ERT’s EXPERT platform with eCI’s product suite. Trial sponsors and CROs will benefit from the rapid deployment of a data integration layer that enables real-time data exchange between systems, the companies say.

The end result will offer CROs and researchers new insight into investigative site and outcomes data activity, risk-based management, enhanced performance measurement, and informed real-time decision-making through a single interface.

By joining ERT’s leading technical and clinical experts, eCI will be able to fulfill its mission of helping research organizations leverage the power of trial data to optimize their business processes​,” said Peg Regan, Founder and CEO of eClinical Insights. “We recognize that technology alone cannot solve the complex challenges of clinical research. The combined experience of ERT and eCI ensures our customers are not simply buying technology, but are gaining a partner with the domain expertise needed to help them succeed​.” 

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us


View more